A handful of companies are blazing a trail from reactionary to proactive medicine in a number of ways. From leveraging genome sequencing on an individual basis, to manipulating big data to mine emerging conditions across entire populations, these companies are leading the way to predict patient diagnosis intervention.

Provider facing finalists Tute Genomics, Share Practice, Chatr Health, Connexient, and Frame Health each had 5 minutes to pitch their business plan followed by 5 minutes of Q&A from our panel of expert judges.